Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Journal of Biotechnology
- Vol. 300, 11-19
Abstract
No abstract availableKeywords
Funding Information
- Hungarian Academy of Sciences (LP2014-7/2014)
- Hungarian National Research, Development and Innovation Fund (FIEK_16-1-2016-0005)
This publication has 55 references indexed in Scilit:
- Maternal plasma soluble endoglin at 11–13 weeks' gestation in pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2010
- Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeksPrenatal Diagnosis, 2010
- A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsiaThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- First-Trimester Prediction of Hypertensive Disorders in PregnancyHypertension, 2009
- First-trimester maternal serum PP13 in the risk assessment for preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- Prediction of Preeclampsia – A Workshop ReportPlacenta, 2008
- The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational ageThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- An integrated model for the prediction of pre-eclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk womenAmerican Journal of Obstetrics and Gynecology, 2006
- Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populationsThe Lancet, 1999